Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma.
| Author | |
|---|---|
| Abstract | :
Fully sialylated alpha-chain of complement 4-binding protein (A2160) is a member of the glycoprotein family and has recently been identified as a diagnostic biomarker for epithelial ovarian cancer. This study examined the utility of A2160 as a prognostic biomarker for this disease. |
| Year of Publication | :
2018
|
| Journal | :
Archives of gynecology and obstetrics
|
| Date Published | :
2018
|
| ISSN Number | :
0932-0067
|
| URL | :
https://dx.doi.org/10.1007/s00404-018-4658-z
|
| DOI | :
10.1007/s00404-018-4658-z
|
| Short Title | :
Arch Gynecol Obstet
|
| Download citation |